Cas:590360-20-6 5-chloro-2-[(3-chlorophenyl)methoxy]benzaldehyde manufacturer & supplier

Chemical Name:5-chloro-2-[(3-chlorophenyl)methoxy]benzaldehyde

CAS.NO:590360-20-6

Synonyms:5-chloro-2-[(3-chlorophenyl)methoxy]benzaldehyde

Molecular Formula:C₁₄H₁₀Cl₂O₂

Molecular Weight:281.13400

HS Code:2913000090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:412.1ºC at 760 mmHg

Density:1.34g/cm3

Index of Refraction:1.623

PSA:26.30000

Exact Mass:280.00600

LogP:4.38490

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-chloro-2-[(3-chlorophenyl)methoxy]benzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-chloro-2-[(3-chlorophenyl)methoxy]benzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-chloro-2-[(3-chlorophenyl)methoxy]benzaldehyde Use and application,5-chloro-2-[(3-chlorophenyl)methoxy]benzaldehyde technical grade,usp/ep/jp grade.

Related News: Looking after their staff: Airlines are under pressure from their staff, who obviously want to protect themselves. 5-chloro-2-[(3-chlorophenyl)methoxy]benzaldehyde manufacturer After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. 5-chloro-2-[(3-chlorophenyl)methoxy]benzaldehyde supplier The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. 5-chloro-2-[(3-chlorophenyl)methoxy]benzaldehyde vendor After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. 5-chloro-2-[(3-chlorophenyl)methoxy]benzaldehyde factory In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.